Mechanisms of allergy and asthma

European Journal of Pharmacology

Volumn 585, Issue 2-3, 2008, Pages 354-360

  Nauta, Alma J ^b   Engels, Ferdi ^a   Knippels, Leon M ^b   Garssen, Johan ^a,b   Nijkamp, Frans P ^a   Redegeld, Frank A ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NUMICO RESEARCH   (Netherlands)

Author keywords

Allergy; Asthma; Eicosanoid; Food allergy; Lipid mediator; Mast cell

Indexed keywords

ALLERGEN; ANTIBIOTIC AGENT; IMMUNOSUPPRESSIVE AGENT; ISOPROSTANE DERIVATIVE; LEUKOTRIENE DERIVATIVE; LINOLEIC ACID; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTANOID; THROMBOXANE A2; VACCINE;

AIR POLLUTION; ALLERGIC ASTHMA; CELL ACTIVATION; CLINICAL FEATURE; DELAYED HYPERSENSITIVITY; DEVELOPED COUNTRY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; FOOD ALLERGY; GENETIC PREDISPOSITION; HELPER CELL; HUMAN; HYGIENE; INFECTION; INFLAMMATORY CELL; INTERVENTION STUDY; MAST CELL; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW;

ANIMALS; ASTHMA; FOOD HYPERSENSITIVITY; HUMANS; HYPERSENSITIVITY; INFLAMMATION MEDIATORS; LIPIDS; MAST CELLS;

EID: 43049111774     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.02.094     Document Type: Review

References (105)

1. Askenase P.W., Van Loveren H., Kraeuter-Kops S., Ron Y., Meade R., Theoharides T.C., Nordlund J.J., Scovern H., Gerhson M.D., and Ptak W. Defective elicitation of delayed-type hypersensitivity in W/Wv and SI/SId mast cell-deficient mice. J. Immunol. 131 (1983) 2687-2694
2. Bach J.F. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347 (2002) 911-920
3. Ball T.M., Castro-Rodriguez J.A., Griffith K.A., Holberg C.J., Martinez F.D., and Wright A.L. Siblings, day-care attendance, and the risk of asthma and wheezing during childhood. N. Engl. J. Med. 343 (2000) 538-543
4. Bock S.A. Prospective appraisal of complaints of adverse reactions to foods in children during the first 3 years of life. Pediatrics 79 (1987) 683-688
5. Bradding P., and Brightling C. Mast cell infiltration of airway smooth muscle in asthma. Respir. Med. 101 (2007) 1045
6. Brightling C., Berry M., and Amrani Y. Targeting TNF-alpha: a novel therapeutic approach for asthma. J. Allergy Clin. Immunol. 121 (2008) 5-10
7. Brightling C.E., Bradding P., Symon F.A., Holgate S.T., Wardlaw A.J., and Pavord I.D. Mast-cell infiltration of airway smooth muscle in asthma. N. Engl. J. Med. 346 (2002) 1699-1705
8. Brown J.M., Wilson T.M., and Metcalfe D.D. The mast cell and allergic diseases: role in pathogenesis and implications for therapy. Clin. Exp. Allergy 38 (2008) 4-18
9. Buchanan A.D., Green T.D., Jones S.M., Scurlock A.M., Christie L., Althage K.A., Steele P.H., Pons L., Helm R.M., Lee L.A., and Burks A.W. Egg oral immunotherapy in nonanaphylactic children with egg allergy. J. Allergy Clin. Immunol. 119 (2007) 199-205
10. Capra V., Thompson M.D., Sala A., Cole D.E., Folco G., and Rovatti G.E. Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: critical update and emerging trends. Med. Res. Rev. 27 (2007) 469-527
11. Chung K.F. Evaluation of selective prostaglandin E2 (PGE2) receptor agonists as therapeutic agents for the treatment of asthma. Sci. STKE 2005 (2005) pe47-pe51
12. Creticos P.S., Chen Y.H., and Schroeder J.T. New approaches in immunotherapy: allergen vaccination with immunostimulatory DNA. Immunol. Allergy Clin. North Am. 24 (2004) 569-581
13. Eigenmann P.A., Sicherer S.H., Borkowski T.A., Cohen B.A., and Sampson H.A. Prevalence of IgE-mediated food allergy among children with atopic dermatitis. Pediatrics 101 (1998) E8
14. Engels F., and Nijkamp F.P. Pharmacological inhibition of leukotriene actions. Pharm. World Sci. 20 (1998) 60-65
15. Engels F., Willems H., and Nijkamp F.P. Cyclooxygenase-catalyzed formation of 9-hydroxylinoleic acid by guinea pig alveolar macrophages under non-stimulated conditions. FEBS Lett. 209 (1986) 249-253
16. Engels F., Henricks P.A.J., Van der Vliet H., and Nijkamp F.P. Modulatory activity of 9-hydroxy- and 9-hydroperoxy-octadecadienoic acid towards reactive oxygen species from guinea-pig pulmonary macrophages. Eur. J. Biochem. 184 (1989) 197-203
17. Engels F., Kessels G.C.R., Schreurs A.J.M., and Nijkamp F.P. Production of arachidonic acid and linoleic acid metabolites by human bronchoalveolar lavage cells. Prostagladin 42 (1991) 441-450
18. Engels F., Kessels G.C.R., Henricks P.A.J., and Nijkamp F.P. Preferential formation of 13-hydroxylinoleic acid by human peripheral blood eosinophils. Prostagladin 52 (1996) 117-124
19. Engels F., Van Houwelingen A.H., Buckley T.L., Van de Velde M.J., Henricks P.A.J., and Nijkamp F.P. Airway hyperresponsiveness induced by 13-hydroxyoctadecadienoic acid (13-HODE) is mediated by sensory neuropeptides. Adv. Prostaglandin Thromboxane Leukotriene Res. 23 (1995) 361-363
20. Gauvreau G.M., Watson R.M., and O'Byrne P.M. Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation. Am. J. Respir. Crit. Care Med. 159 (1999) 31-36
21. Gilfillan A.M., and Tkaczyk C. Integrated signalling pathways for mast-cell activation. Nat. Rev. Immunol. 6 (2006) 218-230
22. Goulet J.L., Pace A.J., Key M.L., Byrum R.S., Nguyen M., Tilley S.L., Morham S.G., Langenbach R., Stock J.L., McNeish J.D., Smithies O., Coffman T.M., and Koller B.H. E-prostanoid-3 receptors mediate the proinflammatory actions of prostaglandin E2 in acute cutaneous inflammation. J. Immunol. 173 (2004) 1321-1326
23. Grimbaldeston M.A., Metz M., Yu M., Tsai M., and Galli S.J. Effector and potential immunoregulatory roles of mast cells in IgE-associated acquired immune responses. Curr. Opin. Immunol. 18 (2006) 751-760
24. Grimbaldeston M.A., Chen C.C., Piliponsky A.M., Tsai M., Tam S.Y., and Galli S.J. Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am. J. Pathol. 167 (2005) 835-848
25. Hamelmann E., and Gelfand E.W. Role of IL-5 in the development of allergen-induced airway hyperresponsiveness. Int. Arch. Allergy Immunol. 120 (1999) 8-16
26. Henricks P.A.J., Engels F., Van der Vliet H., and Nijkamp F.P. 9- and 13-Hydroxy-linoleic acid possess chemotactic activity for bovine and human polymorphonuclear leukocytes. Prostagladin 41 (1991) 21-27
27. Henricks P.A.J., Engels F., Van der Linde H.J., Garssen J., and Nijkamp F.P. 13-Hydroxy-linoleic acid induces airway hyperresponsiveness to histamine and methacholine in guinea pigs in vivo. J. Allergy Clin. Immunol. 96 (1995) 36-43
28. Host A., Halken S., Jacobsen H.P., Eastmann A., Mortensen S., and Mygil S. The natural course of cow's milk protein allergy/intolerance. J. Allergy Clin. Immunol. 99 (1997) S490
29. Huber J., Bochkov V.N., Binder B.R., and Leitinger N. The isoprostane 8-iso-PGE2 stimulates endothelial cells to bind monocytes via cyclic AMP- and p38 MAP kinase-dependent signaling pathways. Antioxid. Redox Signal. 5 (2003) 163-169
30. Janssen L.J., Premji M., Netherton S., Catalli A., Cox G., Keshavjee S., and Crankshaw D.J. Excitatory and inhibitory actions of isoprostanes in human and canine airway smooth muscle. J. Pharmacol. Exp. Ther. 295 (2000) 506-511
31. Kakurai M., Monteforte R., Suto H., Tsai M., Nakae S., and Galli S.J. Mast cell-derived tumor necrosis factor can promote nerve fiber elongation in the skin during contact hypersensitivity in mice. Am. J. Pathol. 169 (2006) 1713-1721
32. Kalliomaki M., Salminen S., Poussa T., Arvilommi H., and Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361 (2003) 1869-1871
33. Karimi K., Redegeld F.A., Heijdra B., and Nijkamp F.P. Stem cell factor and interleukin-4 induce murine bone marrow cells to develop into mast cells with connective tissue type characteristics in vitro. Exp. Hematol. 27 (1999) 654-662
34. Karimi K., Redegeld F.A., Blom R., and Nijkamp F.P. Stem cell factor and interleukin-4 increase responsiveness of mast cells to substance P. Exp. Hematol. 28 (2000) 626-634
35. Kawikova I., Barnes P.J., Takahashi T., Tadjkarimi S., Yacoub M.H., and Belvisi M.G. 8-Epi-PGF2alpha, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro. Am. J. Respir. Crit. Care Med. 153 (1996) 590-596
36. Kim Y.S., Ko H.M., Kang N.I., Song C.H., Zhang X., Chung W.C., Kim J.H., Choi I.H., Park Y.M., Kim G.Y., Im S.Y., and Lee H.K. Mast cells play a key role in the development of late airway hyperresponsiveness through TNF-alpha in a murine model of asthma. Eur. J. Immunol. 37 (2007) 1107-1115
37. Kobayashi T., Miura T., Haba T., Sato M., Serizawa I., Nagai H., and Ishizaka K. An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model. J. Immunol. 164 (2000) 3855-3861
38. Kojima F., Kato S., and Kawai S. Prostaglandin E synthase in the pathophysiology of arthritis. Fundam. Clin. Pharmacol. 19 (2005) 255-261
39. Kraneveld A.D., Buckley T.L., van Heuven-Nolsen D., van Schaik Y., Koster A.S., and Nijkamp F.P. Delayed-type hypersensitivity-induced increase in vascular permeability in the mouse small intestine: inhibition by depletion of sensory neuropeptides and NK1 receptor blockade. Br. J. Pharmacol. 114 (1995) 1483-1489
40. Kraneveld A.D., van der Kleij H.P., Kool M., van Houwelingen A.H., Weitenberg A.C., Redegeld F.A., and Nijkamp F.P. Key role for mast cells in nonatopic asthma. J. Immunol. 169 (2002) 2044-2053
41. Kraneveld A.D., Kool M., van Houwelingen A.H., Roholl P., Solomon A., Postma D.S., Nijkamp F.P., and Redegeld F.A. Elicitation of allergic asthma by immunoglobulin free light chains. Proc. Natl. Acad. Sci. U S A 102 (2005) 1578-1583
42. Kunikata T., Yamane H., Segi E., Matsuoka T., Sugimoto Y., Tanaka S., Tanaka H., Nagai H., Ichikawa A., and Narumiya S. Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3. Nat. Immunol. 6 (2005) 524-531
43. Lee S.Y., Huang C.K., Zhang T.F., Schofield B.H., Burks A.W., Bannon G.A., Sampson H.A., and Li X.M. Oral administration of IL-12 suppresses anaphylactic reactions in a murine model of peanut hypersensitivity. Clin. Immunol. 101 (2001) 220-228
44. Leung D.Y., Sampson H.A., Yunginger J.W., Burks Jr. A.W., Schneider L.C., Wortel C.H., Davis F.M., Hyun J.D., and Shanahan Jr. W.R. Effect of anti-IgE therapy in patients with peanut allergy. N. Engl. J. Med. 348 (2003) 986-993
45. Li Q., Zhang Q., Wang M., Zhao S., Ma J., Luo N., Li N., Li Y., Xu G., and Li J. Interferon-gamma and tumor necrosis factor-alpha disrupt epithelial barrier function by altering lipid composition in membrane microdomains of tight junction. Clin. Immunol. 126 (2007) 67-80
46. Li X.M., Srivastava K., Grishin A., Huang C.K., Schofield B., Burks W., and Sampson H.A. Persistent protective effect of heat-killed Escherichia coli producing "engineered," recombinant peanut proteins in a murine model of peanut allergy. J. Allergy Clin. Immunol. 112 (2003) 159-167
47. Majamaa H., and Isolauri E. Probiotics: a novel approach in the management of food allergy. J. Allergy Clin. Immunol. 99 (1997) 179-185
48. Malbec O., and Daeron M. The mast cell IgG receptors and their roles in tissue inflammation. Immunol. Rev. 217 (2007) 206-221
49. Matsuoka T., Hirata M., Tanaka H., Takahashi Y., Murata T., Kabashima K., Sugimoto Y., Kobayashi T., Ushikubi F., Aze Y., Eguchi N., Urade Y., Yoshida N., Kimura K., Mizoguchi A., Honda Y., Nagai H., and Narumiya S. Prostaglandin D2 as a mediator of allergic asthma. Science 287 (2000) 2013-2017
50. Mayer L. Mucosal immunity and gastrointestinal antigen processing. J. Pediatr. Gastroenterol. Nutr. 30 (2000) S4-S12 Suppl
51. McCurdy J.D., Olynych T.J., Maher L.H., and Marshall J.S. Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J. Immunol. 170 (2003) 1625-1629
52. Meglio P., Bartone E., Plantamura M., Arabito E., and Giampietro P.G. A protocol for oral desensitization in children with IgE-mediated cow's milk allergy. Allergy 59 (2004) 980-987
53. Metz M., Grimbaldeston M.A., Nakae S., Piliponsky A.M., Tsai M., and Galli S.J. Mast cells in the promotion and limitation of chronic inflammation. Immunol. Rev. 217 (2007) 304-328
54. Mickleborough T.D. Dietary omega-3 polyunsaturated fatty acid supplementation and airway hyperresponsiveness in asthma. J. Asthma 42 (2005) 305-314
55. Moro G., Arslanoglu S., Stahl B., Jelinek J., Wahn U., and Boehm G. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch. Dis. Child 91 (2006) 814-819
56. Mortaz E., Redegeld F.A., Nijkamp F.P., Wong H.R., and Engels F. Acetylsalicylic acid-induced release of HSP70 from mast cells results in cell activation through TLR pathway. Exp. Hematol. 34 (2006) 8-18
57. Mowat A.M. Anatomical basis of tolerance and immunity to intestinal antigens. Nat. Rev. Immunol. 3 (2003) 331-341
58. Murata T., Ushikubi F., Matsuoka T., Hirata M., Yamasaki A., Sugimoto Y., Ichikawa A., Aze Y., Tanaka T., Yoshida N., Ueno A., Oh-ishi S., and Narumiya S. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature 388 (1997) 678-682
59. Murray J.J., Tonnel A.B., Brash A.R., Roberts L.J.n., Gosset P., Workman R., Capron A., and Oates J.A. Release of prostaglandin D2 into human airways during antigen challenge. N. Engl. J. Med. 315 (1986) 800-804
60. Nagai H., Arimura A., Yoshitake K., Iwama T., Sakurai T., and Koda A. The effect of a novel thromboxane A2 (TXA2) receptor antagonist (S-1452) on the antigen-induced bronchoconstriction and airway hyperresponsiveness in guinea pigs. Prostagladins Leukot. Essent. Fat. Acids 48 (1993) 343-349
61. Nakae S., Ho L.H., Yu M., Monteforte R., Iikura M., Suto H., and Galli S.J. Mast cell-derived TNF contributes to airway hyperreactivity, inflammation, and TH2 cytokine production in an asthma model in mice. J. Allergy Clin. Immunol. 120 (2007) 48-55
62. Nelson H.S., Lahr J., Rule R., Bock A., and Leung D. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J. Allergy Clin. Immunol. 99 (1997) 744-751
63. Novembre E., de Martino M., and Vierucci A. Foods and respiratory allergy. J. Allergy Clin. Immunol. 81 (1988) 1059-1065
64. Ogawa Y., and Calhoun W.J. The role of leukotrienes in airway inflammation. J. Allergy Clin. Immunol. 118 (2006) 789-798
65. Oosthuizen M.J., Engels F., Van Esch B., Henricks P.A.J., and Nijkamp F.P. Production of arachidonic and linoleic acid metabolites by guinea pig tracheal epithelial cells. Inflammation 14 (1990) 401-408
66. Owen C.E. Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic. Pharmacol. Ther. 113 (2007) 121-133
67. Patriarca G., Nucera E., Roncallo C., Pollastrini E., Bartolozzi F., De Pasquale T., Buonomo A., Gasbarrini G., Di Campli C., and Schiavino D. Oral desensitizing treatment in food allergy: clinical and immunological results. Aliment. Pharmacol. Ther. 17 (2003) 459-465
68. Profita M., Sala A., Bonanno A., Riccobono L., Siena L., Melis M.R., Di Giorgi R., Mirabella F., Gjomarkaj M., Bonsignore G., and Vignola A.M. Increased prostaglandin E2 concentrations and cyclooxygenase-2 expression in asthmatic subjects with sputum eosinophilia. J. Allergy Clin. Immunol. 112 (2003) 709-716
69. Redegeld F.A., van der Heijden M.W., Kool M., Heijdra B.M., Garssen J., Kraneveld A.D., Van Loveren H., Roholl P., Saito T., Verbeek J.S., Claassens J., Koster A.S., and Nijkamp F.P. Immunoglobulin-free light chains elicit immediate hypersensitivity-like responses. Nat. Med. 8 (2002) 694-701
70. Riedler J., Braun-Fahrlander C., Eder W., Schreuer M., Waser M., Maisch S., Carr D., Schierl R., Nowak D., and von Mutius E. Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet 358 (2001) 1129-1133
71. Rijnierse A., Koster A.S., Nijkamp F.P., and Kraneveld A.D. Critical role for mast cells in the pathogenesis of 2,4-dinitrobenzene-induced murine colonic hypersensitivity reaction. J. Immunol. 176 (2006) 4375-4384
72. Rijnierse A., van Zijl K.M., Koster A.S., Nijkamp F.P., and Kraneveld A.D. Beneficial effect of tachykinin NK1 receptor antagonism in the development of hapten-induced colitis in mice. Eur. J. Pharmacol. 548 (2006) 150-157
73. Romagnani S. The role of lymphocytes in allergic disease. J. Allergy Clin. Immunol. 105 (2000) 399-408
74. Romagnani S. Coming back to a missing immune deviation as the main explanatory mechanism for the hygiene hypothesis. J. Allergy Clin. Immunol. 119 (2007) 1511-1513
75. Roosterman D., Goerge T., Schneider S.W., Bunnett N.W., and Steinhoff M. Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiol. Rev. 86 (2006) 1309-1379
76. Sampson H.A. Food allergy. Part 2: diagnosis and management. J Allergy Clin Immunol. 103 (1999) 981-989
77. Sampson H.A. Food allergy. Part 1: immunopathogenesis and clinical disorders. J. Allergy Clin. Immunol. 103 (1999) 717-728
78. Sampson H.A. Utility of food-specific IgE concentrations in predicting symptomatic food allergy. J. Allergy Clin. Immunol. 107 (2001) 891-896
79. Sampson H.A. Update on food allergy. J. Allergy Clin. Immunol. 113 (2004) 805-819
80. Scheerens H., Buckley T.L., Muis T., Van Loveren H., and Nijkamp F.P. The involvement of sensory neuropeptides in toluene diisocyanate-induced tracheal hyperreactivity in the mouse airways. Br. J. Pharmacol. 119 (1996) 1665-1671
81. Scholz H., Yndestad A., Damas J.K., Waehre T., Tonstad S., Aukrust P., and Halvorsen B. 8-Isoprostane increases expression of interleukin-8 in human macrophages through activation of mitogen-activated protein kinases. Cardiovasc. Res. 59 (2003) 945-954
82. Serhan C.N. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu. Rev. Immunol. 25 (2007) 101-137
83. Sheibanie A.F., Yen J.-H., Khayrullina T., Emig F., Zhang M., Tuma R., and Ganea D. The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23 Ä IL-17 axis. J. Immunol. 178 (2007) 8138-8147
84. Siebenhaar F., Magerl M., Peters E.M., Hendrix S., Metz M., and Maurer M. Mast cell-driven skin inflammation is impaired in the absence of sensory nerves. J. Allergy Clin. Immunol (2007) 10.1016/j.physletb.2003.10.071
85. Strachan D.P. Hay fever, hygiene, and household size. Bmj 299 (1989) 1259-1260
86. Sudo N., Sawamura S., Tanaka K., Aiba Y., Kubo C., and Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J. Immunol. 159 (1997) 1739-1745
87. Takahashi Y., Tokuoka S., Masuda T., Hirano Y., Nagao M., Tanaka H., Inagaki N., Narumiya S., and Nagai H. Augmentation of allergic inflammation in prostanoid IP receptor deficient mice. Br. J. Pharmacol. 137 (2002) 315-322
88. Takeda K., Hamelmann E., Joetham A., Shultz L.D., Larsen G.L., Irvin C.G., and Gelfand E.W. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J. Exp. Med. 186 (1997) 449-454
89. Taube C., Wei X., Swasey C.H., Joetham A., Zarini S., Lively T., Takeda K., Loader J., Miyahara N., Kodama T., Shultz L.D., Donaldson D.D., Hamelmann E.H., Dakhama A., and Gelfand E.W. Mast cells, Fc epsilon RI, and IL-13 are required for development of airway hyperresponsiveness after aerosolized allergen exposure in the absence of adjuvant. J. Immunol. 172 (2004) 6398-6406
90. Theoharides T.C., and Kalogeromitros D. The critical role of mast cells in allergy and inflammation. Ann. N. Y. Acad. Sci. 1088 (2006) 78-99
91. Theoharides T.C., Kempuraj D., Tagen M., Conti P., and Kalogeromitros D. Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol. Rev. 217 (2007) 65-78
92. Umetsu D.T., and DeKruyff R.H. TH1 and TH2 CD4+ cells in human allergic diseases. J. Allergy Clin. Immunol. 100 (1997) 1-6
93. Van de Velde M.J., Engels F., Henricks P.A.J., and Nijkamp F.P. 13-HODE inhibits the intracellular calcium increase of activated human polymorphonuclear cells. J. Leukoc. Biol. 56 (1994) 200-202
94. Van de Velde M.J., Engels F., Henricks P.A.J., Bloemen P.G.M., and Nijkamp F.P. The linoleic acid metabolite 13-HODE modulates degranulation of human polymorphonuclear leukocytes. FEBS Lett. 369 (1995) 301-304
95. Van der Heijden M.W., Van der Kleij H.P.M., Roecken M., and Redegeld F.A. Mast cells. In: Bos J.D. (Ed). The Skin Immune System. third ed. (2005), CRC Press, Boca Raton, FL 237-261
96. van der Kleij H.P., Kraneveld A.D., Redegeld F.A., Gerard N.P., Morteau O., and Nijkamp F.P. The tachykinin NK1 receptor is crucial for the development of non-atopic airway inflammation and hyperresponsiveness. Eur. J. Pharmacol. 476 (2003) 249-255
97. Vliagoftis H., and Befus A.D. Mast cells at mucosal frontiers. Curr. Mol. Med. 5 (2005) 573-589
98. von Mutius E., Martinez F.D., Fritzsch C., Nicolai T., Roell G., and Thiemann H.H. Prevalence of asthma and atopy in two areas of West and East Germany. Am. J. Respir. Crit. Care Med. 149 (1994) 358-364
99. Weiner H.L. Oral tolerance, an active immunologic process mediated by multiple mechanisms. J. Clin. Invest. 106 (2000) 935-937
100. Wenzel S.E., Westcott J.Y., and Larsen G.L. Bronchoalveolar lavage fluid mediator levels 5 minutes after allergen challenge in atopic subjects with asthma: relationship to the development of late asthmatic responses. J. Allergy Clin. Immunol. 87 (1991) 540-548
101. Williams C.M., and Galli S.J. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J. Exp. Med. 192 (2000) 455-462
102. Wong B.R., Grossbard E.B., Payan D.G., and Masuda E.S. Targeting Syk as a treatment for allergic and autoimmune disorders. Expert Opin. Investig. Drugs 13 (2004) 743-762
103. Yazdanbakhsh M., Kremsner P.G., and van Ree R. Allergy, parasites, and the hygiene hypothesis. Science 296 (2002) 490-494
104. Yong L.C. The mast cell: origin, morphology, distribution, and function. Exp. Toxicol. Pathol. 49 (1997) 409-424
105. Yu M., Tsai M., Tam S.Y., Jones C., Zehnder J., and Galli S.J. Mast cells can promote the development of multiple features of chronic asthma in mice. J. Clin. Invest. 116 (2006) 1633-1641